Blood test may let kidney patients ditch multiple Anti-Rejection drugs
NCT ID NCT04786067
First seen Jan 12, 2026 · Last updated May 01, 2026 · Updated 15 times
Summary
This study looked at 25 kidney transplant patients to see if a blood test (AlloSure) could help them safely switch from several anti-rejection drugs to just one, Belatacept. The goal was to keep the new kidney healthy while reducing medication side effects. Researchers checked for rejection using kidney biopsies and followed patients for up to 3 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT IMMUNOSUPPRESSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.